Y-mAbs Therapeutics, Inc. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Y-mAbs Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2017 to Q3 2024.
  • Y-mAbs Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2024 was -$480M, a 5.23% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$480M -$23.9M -5.23% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$473M -$24.6M -5.49% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$464M -$21.7M -4.9% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$457M -$21.4M -4.91% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 -$456M -$19.3M -4.41% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$449M -$39.1M -9.54% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$442M -$73.9M -20% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 -$436M -$95.6M -28.1% Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$437M -$134M -44% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 -$410M -$135M -49.1% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$369M -$117M -46.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$340M -$55.3M -19.4% Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$304M -$38.3M -14.4% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$275M -$42.3M -18.2% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 -$252M -$59.7M -31.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$285M -$119M -71.9% Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$265M -$123M -85.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$232M -$114M -95.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 -$192M -$91.3M -90.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 -$166M -$81M -95.5% Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$143M -$72M -102% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 -$119M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 -$101M Mar 31, 2019 10-Q 2019-05-10
Q4 2018 -$84.8M -$43.3M -104% Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$70.8M Sep 30, 2018 10-Q 2018-11-13
Q4 2017 -$41.6M Dec 31, 2017 10-K 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.